Manhattan Pharmaceuticals is acquiring Ariston in a stock deal valued at $564,800

Ariston Pharmaceuticals Inc.

U.S. / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Manhattan Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed